Overview


According to FutureWise analysis the market for allergy shots in 2023 is US$ 2.43 billion, and is expected to reach US$ 2.97 billion by 2031 at a CAGR of 10.60%.

Allergen immunotherapy, often known as allergy shots, is a type of long-term treatment that helps many patients suffering from allergic rhinitis, allergic asthma, conjunctivitis (eye allergy), or stinging insect allergy. Allergy shots reduce sensitivity to allergens and frequently result in long-term alleviation of allergy symptoms even when treatment is discontinued. As a result, it is a cost-effective and helpful therapy option for a large number of patients. Allergy shots can be given to children and adults, but it is not usually recommended for children under five. This is because younger children may have difficulty cooperating with the program and communicating any negative symptoms they may be feeling. When considering allergy shots for elderly individuals, medical concerns such as cardiac disease should be considered and discussed with an allergist/immunologist first.

Allergy shots are particularly useful for those whose allergy symptoms are not well-controlled with medications or who prefer a long-term solution that reduces their reliance on continuous medication use. They provide a targeted and personalized approach to managing allergies by modifying the body's immune response to specific allergens. This treatment is often recommended for individuals who experience significant allergic symptoms or have a high risk of severe reactions. Additionally, allergy shots can be administered to children who have substantial allergies and have not responded well to other treatments. However, the suitability and safety of allergy shots for children should be evaluated by a healthcare professional experienced in paediatric allergy care.

FutureWise Market Research has published a report that provides an insightful analysis of Allergy Shots Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the Allergy Shots Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • ALK Abello
  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Anergis
  • Arrayit Corporation
  • Biomay AG
  • HAL Allergy Group
  • DBV Technologies

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing incidence of various allergy types is expected to drive the growth of the allergy shots market. Allergies, such as allergic rhinitis, asthma, and food allergies, are becoming more prevalent worldwide. Factors such as environmental changes, exposure to allergens, and genetic predisposition contribute to the rising incidence of allergies. As the number of individuals affected by allergies continues to increase, there is a growing demand for effective treatment options. Allergy shots, or allergen immunotherapy, have been proven to be an effective long-term solution for managing allergies. They target the root cause of allergies by desensitizing the immune system to specific allergens, thereby reducing the severity of allergic reactions. Moreover, SCIT has been extensively studied and shown to be effective in reducing symptoms and improving quality of life for individuals with allergies, particularly respiratory allergies like allergic rhinitis and allergic asthma. It has also demonstrated the ability to prevent the progression of allergic rhinitis to asthma in some cases.  With the rising awareness about the benefits of allergy shots and their ability to provide long-lasting relief, more individuals are seeking this treatment option. Thus, further driving market growth. However, The lengthy treatment time required for allergy shots can indeed pose a challenge for the allergy shots market. The extended treatment duration can deter some individuals from pursuing allergy shots. It requires consistent adherence to the treatment schedule and regular visits to healthcare providers for injections. This can be burdensome for individuals with busy schedules or those who may have difficulty committing to long-term treatment. Moreover, the time it takes to achieve noticeable symptom improvement varies among individuals. Due to above mention factors the market is expected to grow slowly.

By Product

  • SLIT Tablets
  • Oral
  • Injections

By Immunotherapy

  • Sublingual Immunotherapy
  • Subcutaneous Immunotherapy

By Indication

  • Allergic Rhinitis
  • Allergic Asthma
  • Food Allergy
  • Atopic Dermatitis

By Allergan

  • Pollens
  • House Dust Mites (HDM)
  • Mould
  • Animal Dander
  • Bee Venom
  • Cockroaches/Insects

By Distribution Channel

  • Institutional Sales
    • Government Hospitals
    • Semi-government Hospitals
    • Private Hospitals
  • Retail Sales

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The rise is attributable to variables such as an increase in allergy cases and increased awareness of allergy therapy. For example, according to research issued in May 2022 by the International Food Information Council, around 32.0 million people in the United States have reported having food allergies, and approximately 200,000 people require emergency medical care each year owing to food allergies. It also stated that food allergies were frequent among children, with around one in every 13 children in the United States being diagnosed with a food allergy, and approximately 40.0% of children with food allergies being allergic to more than one food. Such incidents are expected to increase demand for allergy immunotherapy in this region.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Allergy Shots Market By Product, By Immunotherapy, By Allergen, By Indication, By Distribution Channel, And By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Allergy Shots Market Variables, Trends and Scope
    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Allergy Shots Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Allergy Shots Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Allergy Shots Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. SLIT Tablets
        2. Oral
        3. Injections

  • 8.   Allergy Shots Market, By Immunotherapy Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Sublingual Immunotherapy
        2. Subcutaneous Immunotherapy

  • 9.   Allergy Shots Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pollens
        2. House Dust Mites (HDM)
        3. Mould
        4. Animal Dander
        5. Bee Venom
        6. Cockroaches/Insects

  • 10.   Allergy Shots Market, By Allergan Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Institutional Sales
         1.1. Government Hospitals
         1.2. Semi-government Hospitals
         1.3. Private Hospitals
        2. Retail Sales

  • 11.   Allergy Shots Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Allergic Rhinitis
        2. Allergic Asthma
        3. Food Allergy
        4. Atopic Dermatitis

  • 12.   North America Allergy Shots Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Allergy Shots Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Allergy Shots Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Allergy Shots Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Allergy Shots Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. ALK Abello
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Stallergenes Greer
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Allergy Therapeutics
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Aimmune Therapeutics
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Anergis
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Arrayit Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Biomay AG
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. HAL Allergy Group
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. DBV Technologies
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients